- Profile
- Personal Information
- Publications
Experts in Ophthalmology
Rando Allikmets PAN Shilie YANG Zhihua Xin Zhang Mohamed Abou Shousha Chrisfouad R. Alabiad Thomas Albini Eduardo Alfonso Jane Koretz Guillermo Amescua Richard M. Awdeh James Banta Audina M. Berrocal Byoung Seung Ham Hilda Capo Manjusha Rajagopala Kara M. Cavuoto Ta Chen P. Chang Victoria Chang Esen K Akpek View MoreJoseph S. Jensen
President, CEO & Director
ophthalmology
TearLab Corporation
United States of America
Mr. Joseph S. Jensen, also known as Seph, has been the Chief Executive Officer of TearLab Corporation since January 1, 2016 as its President since October 1, 2013. Mr. Jensen served as the Chief Operating Officer of TearLab Corporation from October 1, 2013 to January 1, 2016. He has an important depth of knowledge of the global ophthalmic pharma and device space to TearLab's management team. He has an accomplished history of sales and marketing, operations and general management success in the ophthalmic industry. He served as Head of Surgical Marketing at Alcon Laboratories Inc. ("Alcon"), having responsibility for more than $1.4 billion in revenue across its cataract, retina and refractive businesses. His 17 years of progressive experience at Alcon includes previous roles managing its full surgical equipment portfolio in the United States, leading its surgical retina equipment portfolio globally, managing its pharmaceutical products marketing in Japan and various other commercial assignments. Mr. Jensen has been a Director of TearLab Corporation since January 2016. Mr. Joseph S. Jensen, also known as Seph, has been the Chief Executive Officer of TearLab Corporation since January 1, 2016 as its President since October 1, 2013. Mr. Jensen served as the Chief Operating Officer of TearLab Corporation from October 1, 2013 to January 1, 2016. He has an important depth of knowledge of the global ophthalmic pharma and device space to TearLab's management team. He has an accomplished history of sales and marketing, operations and general management success in the ophthalmic industry. He served as Head of Surgical Marketing at Alcon Laboratories Inc. ("Alcon"), having responsibility for more than $1.4 billion in revenue across its cataract, retina and refractive businesses. His 17 years of progressive experience at Alcon includes previous roles managing its full surgical equipment portfolio in the United States, leading its surgical retina equipment portfolio globally, managing its pharmaceutical products marketing in Japan and various other commercial assignments. Mr. Jensen has been a Director of TearLab Corporation since January 2016.
Ophthalmic Pathology